OVERVIEW

The Overlooked Connection – Why You Should Screen for Hypercortisolism in Type 2 Diabetes is organized by Association of Diabetes Care & Education Specialists (ADCES).

Originally presented on: 4/29/2025
Expiration date: 4/29/2027

Description:
Join us for an insightful webinar exploring the evolving landscape of hypercortisolism, from its historical origins to the latest advancements in screening and clinical management. Our expert speakers will provide a comprehensive overview, beginning with a historical perspective on Cushing syndrome and the progressive understanding of hypercortisolism. The session will then delve into key screening guidelines, including the physiological basis of the dexamethasone suppression test, to enhance early detection. Finally, we will examine the intersection of hypercortisolism and challenging-to-manage type 2 diabetes (T2D), discussing emerging data on its prevalence, clinical implications, and best practices for identifying at-risk individuals. This webinar is essential for healthcare professionals looking to refine their approach to diagnosing and managing hypercortisolism in complex patient populations.

Learning Objectives:
At the end of this presentation, participants will be able to:

Recognize the evolving understanding of hypercortisolism and its relevance in modern clinical practice.
Apply evidence-based recommendations for selecting and interpreting initial screening tests for hypercortisolism.
Evaluate the prevalence and impact of hypercortisolism in individuals with challenging-to-manage T2D.